Quick Answer
CervoMed Inc. reported Operating Income of -$28.29 million for fiscal year 2025.
CervoMed Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$28.29M | -55.2% |
| 2024 | -$18.23M | -133.3% |
| 2023 | -$7.81M | -124.8% |
| 2022 | -$3.48M | +85.9% |
| 2021 | -$24.68M | -54.5% |
| 2020 | -$15.97M | -38.3% |
| 2019 | -$11.55M | +39.1% |
| 2018 | -$18.96M | -67.1% |
| 2017 | -$11.35M | +38.2% |
| 2016 | -$18.37M | -186.8% |
| 2015 | -$6.41M | +56.2% |
| 2014 | -$14.61M | -14.2% |
| 2013 | -$12.80M | +22.1% |
| 2011 | -$16.43M | -115.1% |
| 2010 | -$7.64M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$8.04M | -49.1% | -21.6% |
| June 30, 2025 | -$6.62M | -120.9% | -24.8% |
| March 31, 2025 | -$5.30M | -104.4% | +1.7% |
| September 30, 2024 | -$5.40M | -101.7% | -80.2% |
| June 30, 2024 | -$3.00M | -143.3% | -15.4% |
| March 31, 2024 | -$2.59M | -81.9% | +3.0% |
| September 30, 2023 | -$2.68M | -195.9% | -117.3% |
| June 30, 2023 | -$1.23M | +71.0% | +13.7% |
- CervoMed Inc. showed a decrease of -55.2% in Operating Income compared to the prior fiscal year.
- Over the 2010–2025 period, CervoMed Inc.’s operating income has declined by 270.5% (from -$7.64 million to -$28.29 million).
- The most recent figure is from CervoMed Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: